REG - FIL Limited Covidien plc Medtronic, Inc. - Form 8.3 - [Covidien Plc] <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 5257UFIL Limited16 October 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE1. KEY INFORMATION
Name of person dealing (Note 1)
FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
COVIDIEN PLC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
15-October-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
18,836,849 4.17
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
18,836,849 4.17
b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(91) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
(91) Purchases and sales
Purchase/sale
Number of securities
Price per unit
Sale
100,729
86.3016 USD/ Share
Sale
39,800
86. USD/ Share
Buy
37,100
83.58 USD/ Share
Sale
41,800
82.75 USD/ Share
Sale
80,000
84.3 USD/ Share
Sale
100,000
84.25 USD/ Share
Sale
54,300
83.548 USD/ Share
Sale
1,400
83.6679 USD/ Share
Sale
20,960
83.6638 USD/ Share
Sale
1,698
83.6838 USD/ Share
Sale
2,300
83.7004 USD/ Share
Sale
400
83.65 USD/ Share
Sale
1,300
83.5477 USD/ Share
Sale
8,200
83.539 USD/ Share
Sale
159,943
85.8046 USD/ Share
Sale
108,300
85.73 USD/ Share
Sale
37,100
83.58 USD/ Share
Sale
7,300
84. USD/ Share
Sale
126,034
88.6677 USD/ Share
Buy
26,300
88.9688 USD/ Share
Buy
3,100
83.8398 USD/ Share
Sale
31,100
88.4764 USD/ Share
Sale
3,700
88.4932 USD/ Share
Sale
10,700
88.5574 USD/ Share
Sale
6,059
88.3666 USD/ Share
Sale
7,041
88.7695 USD/ Share
Buy
35,500
85.8848 USD/ Share
Buy
41,800
82.75 USD/ Share
Buy
108,300
85.73 USD/ Share
Buy
9
92.63 USD/ Share
Buy
68
93.08 USD/ Share
Buy
4
92.29 USD/ Share
Buy
31
92.70 USD/ Share
Sale
6
92.46 USD/ Share
Sale
1
93.03 USD/ Share
Buy
49
92.48 USD/Share
Sale
5
92.61 USD/ Share
Sale
13
92.65 USD/ Share
(b) Derivatives transactions (other than options transactions)
Product name,
e.g. CFD
Nature of transaction (Note 6)
Number of securities (Note 7)
Price per unit (Note 5)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?(Note 9)NO
Date of disclosure
16 October 2014
Contact name
Alex Hagel
Telephone number
+44 (0)1737 837092
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEBXBDGXUBBGSL
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement